For dichotomous outcomes (dropout rates and adverse events), we computed pooled odds ratios (OR)
However, both may influence blood glucose levels and gastrointestinal function through different mechanisms, requiring medical oversight when used together
They helped me reach my goals
GLP-1R agonists represents a novel class of anti-hyperglycemic agent that improve health and survival of -cells (improvement in postprandial hyperglycemia), suppress glucagon (improvement in fasting hyperglycemia), improve insulin resistance (modest effect) and influence energy intake (augment satiety signal) with minimal, if at all, any side effects (weight neutral and non-hypoglycemic)
Applications are usually once per day or twice per day depending on the product line and what you are treating
Zengo is an excellent advisor and teacher, he always answered my questions in less than 4-6 hours and his advice is priceless